We comply with the
HONcode standard for trustworthy health information:
verify here

174 participating centres from 28 European countries are cooperating in the European Leukemia Net (funded by the 6th Framework Program of the European Community)

News

50th ASH Annual Meeting

December 6-9 2008; San Francisco, USA, Agendae of the ELN-Projects

Registry of CML patients in failure after Imatinib

Although imatinib is now the first line therapy for chronic myelogenous leukemia patients, experimental and clinical studies suggest that imatinib as a single drug might not be sufficient to eradicate Ph-positive stem cells.

Targeted CML Therapy

Meeting 17-19 October 2008, Cannes, France

CML-Workshop 2008

17th International CML Workshop / Satellite Workshop EUTOS for CML
July 4-5, 2008, DKFZ, Heidelberg/Germany

Events
Fr 2009/01/30 - Sa 2009/01/31 Highlights of ASH
Mo 2009/02/02 - Th 2009/02/05 ELN Symposium 2009
Th 2009/02/05 - Fr 2009/02/06 ACI's National Conference on Successful Strategies for Genetic and Molecular Diagnostic Testing
Fr 2009/02/06 - Sa 2009/02/07 Highlights of ASH
Th 2009/05/14 - Su 2009/05/17 BMHG- 8th Balkan Meeting on Human Genetics

The European Leukemia Net

The objective is to integrate the 78 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 83 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care more...

leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה,

Dates & Meetings

January 2009

« | »

February 2009

« | »

RSS

Online Registration

How to join the European LeukemiaNet

European Leukemia Trial Registry (ELTR)

European Treatment and Outcome Study

EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe